Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients

Roberto Fogari, Gian Malamani, Luca Corradi, Amedeo Mugellini, Paola Preti, Annalisa Zoppi, Giuseppe Derosa

Research output: Contribution to journalArticle

Abstract

Introduction: The objective of this study was to compare the effect on ankle edema of adding valsartan (V) or olmesartan (O) to amlodipine (A) in the treatment of hypertension. Methods: After a 4-week placebo period, 74 adult outpatients with essential hypertension (diastolic blood pressure [DBP] >90 and 140 mmHg) were treated with A 10 mg once daily for 4 weeks. Thereafter, nonresponder patients (DBP >90 mmHg and/or SBP >140 mmHg; n=51) were randomized to receive additional V 160 mg once daily or O 20 mg once daily for 8 weeks in two crossover periods, each separated by a 4-week placebo period. Clinic blood pressure (BP), heart rate, and ankle/foot volume (AFV) were evaluated and blood samples were drawn to evaluate plasma norepinephrine (NE) levels. Results: Both V/A and O/A induced a greater SBP/DBP reduction than A monotherapy (-26.4/-20.8 mmHg and -24.4/-19.1 mmHg, respectively; all P

Original languageEnglish
Pages (from-to)48-55
Number of pages8
JournalAdvances in Therapy
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Valsartan
Amlodipine
Ankle
Edema
Blood Pressure
Placebos
antineoplaston A10
olmesartan
Foot
Norepinephrine
Outpatients

Keywords

  • Amlodipine
  • Ankle edema
  • Combination therapy
  • Hypertens ion
  • Olmesartan
  • Valsartan

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients. / Fogari, Roberto; Malamani, Gian; Corradi, Luca; Mugellini, Amedeo; Preti, Paola; Zoppi, Annalisa; Derosa, Giuseppe.

In: Advances in Therapy, Vol. 27, No. 1, 01.2010, p. 48-55.

Research output: Contribution to journalArticle

@article{623ccdd05dab454080baf9fc8a0015bd,
title = "Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients",
abstract = "Introduction: The objective of this study was to compare the effect on ankle edema of adding valsartan (V) or olmesartan (O) to amlodipine (A) in the treatment of hypertension. Methods: After a 4-week placebo period, 74 adult outpatients with essential hypertension (diastolic blood pressure [DBP] >90 and 140 mmHg) were treated with A 10 mg once daily for 4 weeks. Thereafter, nonresponder patients (DBP >90 mmHg and/or SBP >140 mmHg; n=51) were randomized to receive additional V 160 mg once daily or O 20 mg once daily for 8 weeks in two crossover periods, each separated by a 4-week placebo period. Clinic blood pressure (BP), heart rate, and ankle/foot volume (AFV) were evaluated and blood samples were drawn to evaluate plasma norepinephrine (NE) levels. Results: Both V/A and O/A induced a greater SBP/DBP reduction than A monotherapy (-26.4/-20.8 mmHg and -24.4/-19.1 mmHg, respectively; all P",
keywords = "Amlodipine, Ankle edema, Combination therapy, Hypertens ion, Olmesartan, Valsartan",
author = "Roberto Fogari and Gian Malamani and Luca Corradi and Amedeo Mugellini and Paola Preti and Annalisa Zoppi and Giuseppe Derosa",
year = "2010",
month = "1",
doi = "10.1007/s12325-010-0002-0",
language = "English",
volume = "27",
pages = "48--55",
journal = "Advances in Therapy",
issn = "0741-238X",
publisher = "Springer Healthcare",
number = "1",

}

TY - JOUR

T1 - Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients

AU - Fogari, Roberto

AU - Malamani, Gian

AU - Corradi, Luca

AU - Mugellini, Amedeo

AU - Preti, Paola

AU - Zoppi, Annalisa

AU - Derosa, Giuseppe

PY - 2010/1

Y1 - 2010/1

N2 - Introduction: The objective of this study was to compare the effect on ankle edema of adding valsartan (V) or olmesartan (O) to amlodipine (A) in the treatment of hypertension. Methods: After a 4-week placebo period, 74 adult outpatients with essential hypertension (diastolic blood pressure [DBP] >90 and 140 mmHg) were treated with A 10 mg once daily for 4 weeks. Thereafter, nonresponder patients (DBP >90 mmHg and/or SBP >140 mmHg; n=51) were randomized to receive additional V 160 mg once daily or O 20 mg once daily for 8 weeks in two crossover periods, each separated by a 4-week placebo period. Clinic blood pressure (BP), heart rate, and ankle/foot volume (AFV) were evaluated and blood samples were drawn to evaluate plasma norepinephrine (NE) levels. Results: Both V/A and O/A induced a greater SBP/DBP reduction than A monotherapy (-26.4/-20.8 mmHg and -24.4/-19.1 mmHg, respectively; all P

AB - Introduction: The objective of this study was to compare the effect on ankle edema of adding valsartan (V) or olmesartan (O) to amlodipine (A) in the treatment of hypertension. Methods: After a 4-week placebo period, 74 adult outpatients with essential hypertension (diastolic blood pressure [DBP] >90 and 140 mmHg) were treated with A 10 mg once daily for 4 weeks. Thereafter, nonresponder patients (DBP >90 mmHg and/or SBP >140 mmHg; n=51) were randomized to receive additional V 160 mg once daily or O 20 mg once daily for 8 weeks in two crossover periods, each separated by a 4-week placebo period. Clinic blood pressure (BP), heart rate, and ankle/foot volume (AFV) were evaluated and blood samples were drawn to evaluate plasma norepinephrine (NE) levels. Results: Both V/A and O/A induced a greater SBP/DBP reduction than A monotherapy (-26.4/-20.8 mmHg and -24.4/-19.1 mmHg, respectively; all P

KW - Amlodipine

KW - Ankle edema

KW - Combination therapy

KW - Hypertens ion

KW - Olmesartan

KW - Valsartan

UR - http://www.scopus.com/inward/record.url?scp=77950692356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950692356&partnerID=8YFLogxK

U2 - 10.1007/s12325-010-0002-0

DO - 10.1007/s12325-010-0002-0

M3 - Article

C2 - 20174905

AN - SCOPUS:77950692356

VL - 27

SP - 48

EP - 55

JO - Advances in Therapy

JF - Advances in Therapy

SN - 0741-238X

IS - 1

ER -